Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Research & Development : $9,673.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Bristol-Myers Squibb Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Bristol-Myers Squibb Co's Research & Development for the three months ended in Mar. 2024 was $2,695.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $9,673.00 Mil.

Bristol-Myers Squibb Co Research & Development Historical Data

The historical data trend for Bristol-Myers Squibb Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Research & Development Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

6,148.00

11,143.00

10,195.00

9,509.00

9,299.00

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Research & Development	Get a 7-Day Free Trial															2,321.00	2,258.00	2,242.00	2,478.00	2,695.00

Bristol-Myers Squibb Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $9,673.00 Mil.

Bristol-Myers Squibb Co (NYSE:BMY.R) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Bristol-Myers Squibb Co Research & Development Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (NYSE:BMY.R) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.